Prague Med. Rep. 2013, 114, 57-71

https://doi.org/10.14712/23362936.2014.24

Peri-operative Chemotherapy in Patients with Oesophageal and Gastro-oesophageal Junction Cancer – Three Years of Experience

Z. Pechačová1, Milada Zemanová1,*,  T. Haruštiak2, P. Vítek3, P. Fencl4

1Department of Oncology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
23rd Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
3Institute of Radiation Oncology, First Faculty of Medicine, Charles University in Prague and Hospital Bulovka, Prague, Czech Republic
4PET Centre, Hospital Na Homolce, Prague, Czech Republic

Crossref Cited-by Linking

  • Harustiak T., Zemanova M., Fencl P., Hornofova L., Pazdro A., Snajdauf M., Salkova E., Lischke R., Stolz A.: [18F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction. British Journal of Surgery 2018, 105, 419. <https://doi.org/10.1002/bjs.10712>
  • Fencl Pavel, Belohlavek Otakar, Harustiak Tomas, Zemanova Milada: FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction. Abdom Radiol 2016, 41, 2089. <https://doi.org/10.1007/s00261-016-0820-x>
Crossref Cited-by Linking logo